Home Federal Bank Of Tennessee Amgen Inc Transaction History

Home Federal Bank Of Tennessee

$349 Million
Q3 2024

A detailed history of Home Federal Bank Of Tennessee transactions in Amgen Inc stock. As of the latest transaction made, Home Federal Bank Of Tennessee holds 2,598 shares of AMGN stock, worth $672,310. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,598

Previous 2,497 4.04%

Holding current value

$672,310

Previous $780,000 7.31%

% of portfolio

0.24%

Previous 0.24%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $31,247 - $34,075	101 Added 4.04%	2,598 $837,000
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $64,111 - $77,911	244 Added 10.83%	2,497 $780,000
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $4,839 - $5,842	-18 Reduced 0.79%	2,253 $640,000
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $1,789 - $2,019	-7 Reduced 0.31%	2,271 $654,000
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $26,675 - $33,118	-122 Reduced 5.08%	2,278 $612,000
Q2 2023 Jul 18, 2023	SELL	$214.27 - $253.37 $10,713 - $12,668	-50 Reduced 2.04%	2,400 $532,000
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $3,386 - $4,128	15 Added 0.62%	2,450 $592,000
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $68,709 - $87,303	300 Added 14.05%	2,435 $0
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $19,610 - $21,822	85 Added 4.15%	2,135 $519,000
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $32,890 - $36,385	150 Added 7.89%	2,050 $496,000
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $83,529 - $95,592	420 Added 28.38%	1,900 $428,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $35,024 - $41,035	165 Added 12.55%	1,480 $314,000
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $307,157 - $340,769	1,315 New	1,315 $320,000

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $138B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Home Federal Bank Of Tennessee, based on Form 13F filings with the SEC.

News

Stay updated on Home Federal Bank Of Tennessee with notifications on news.

Account

Home Federal Bank Of Tennessee Amgen Inc Transaction History